HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizabeth G Brudney Selected Research

1-hydroxy-3-amino-2-pyrrolidone

1/2008Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elizabeth G Brudney Research Topics

Disease

2Dyskinesias (Dyskinesia)
07/2009 - 01/2008
2Parkinson Disease (Parkinson's Disease)
07/2009 - 01/2008
1Schizophrenia (Dementia Praecox)
07/2009

Drug/Important Bio-Agent (IBA)

2alpha- (4- fluorophenyl)- 4- (5- fluoro- 2- pyrimidinyl)- 1- piperazine butanolIBA
07/2009 - 01/2008
2Levodopa (L Dopa)FDA LinkGeneric
07/2009 - 01/2008
2Oxidopamine (6 Hydroxydopamine)IBA
07/2009 - 01/2008
11-hydroxy-3-amino-2-pyrrolidoneIBA
01/2008
1LigandsIBA
01/2008
1Amantadine (Aman)FDA LinkGeneric
01/2008
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
01/2008
1Dizocilpine Maleate (Dizocilpine)IBA
01/2008
1N-Methylaspartate (NMDA)IBA
01/2008